Article Versions Notes

Ruscitti P, Liakouli V, Panzera N, Angelucci A, Berardicurti O, Di Nino E, Navarini L, Vomero M, Ursini F, Mauro D, et al. Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6. Pharmaceuticals. 2022; 15(5):622. https://doi.org/10.3390/ph15050622

Ruscitti, Piero, Vasiliki Liakouli, Noemi Panzera, Adriano Angelucci, Onorina Berardicurti, Elena Di Nino, Luca Navarini, Marta Vomero, Francesco Ursini, Daniele Mauro, and et al. 2022. "Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6" Pharmaceuticals 15, no. 5: 622. https://doi.org/10.3390/ph15050622

Ruscitti, P., Liakouli, V., Panzera, N., Angelucci, A., Berardicurti, O., Di Nino, E., Navarini, L., Vomero, M., Ursini, F., Mauro, D., Dolo, V., Ciccia, F., Giacomelli, R., & Cipriani, P. (2022). Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6. Pharmaceuticals, 15(5), 622. https://doi.org/10.3390/ph15050622